NET PROFIT (x1000 SEK)
EMPLOYEES
Solural Pharma ApS
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
2,047
|
9,064
|
4,078 |
| Total assets |
14,705
|
19,492
|
12,596 |
| Current assets |
13,096
|
17,890
|
11,313 |
| Current liabilities |
4,231
|
4,579
|
2,862 |
| Equity capital |
10,474
|
14,911
|
9,734 |
| - share capital |
119
|
120
|
110 |
| Employees (average) |
7
|
7
|
7 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
71.2%
|
76.5%
|
77.3% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
309.5%
|
390.7%
|
395.3% |
| Return on equity (ROE) |
19.5%
|
60.8%
|
41.9% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.